(2S, 4R)-ketoconazole sulfonamide analogs (GVK Biosciences Private/Temple University)

N/A

Report date: 2025/01/26 19:15:35
NME

Base Information

Drug Name(2S, 4R)-ketoconazole sulfonamide analogs (GVK Biosciences Private/Temple University)
Drug Alias Namecytochrome P450-11B/17/21 enzyme inhibitors (GVK Biosciences/Temple University School of Pharmacy)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitorsSteroid 11-beta-hydroxylase inhibitorsSteroid 21 hydroxylase inhibitors
TargetsSteroid 21 hydroxylaseSteroid 17-alpha-hydroxylaseSteroid 11-beta-hydroxylase
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAragen Life Sciences Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTemple UniversityAragen Life Sciences Pvt Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A